Association between eupatilin and reduction in small bowel bleeding in aspirin users and aspirin plus acid suppressant users
Hyun Seok Lee, Ji Hyung Nam, Dong Jun Oh, Hyun Jung Ahn, Yun Jeong Lim
Korean J Intern Med. 2023;38(4):484-492. Published online 2023 May 19 DOI: https://doi.org/10.3904/kjim.2022.340
Citations to this article as recorded by 
Risk of Lower Gastrointestinal Bleeding in Nonsteroidal Anti-inflammatory Drug (NSAID) and Proton Pump Inhibitor Users Compared with NSAID-Only Users: A Common Data Model Analysis
Moonhyung Lee, Myoungsuk Kim, Jae Myung Cha
Gut and Liver.2025; 19(2): 243. CrossRef
Blood pressure levels and risk of end-stage renal disease in patients with type 2 diabetes who underwent percutaneous coronary intervention: a nationwide population-based study
Hyunglae Kim, Yong-Moon Park, Seung-Hyun Ko, Yun-Jung Cho, Hyung Wook Kim, Yong Kyun Kim, Kyung-Do Han, Jae-Seung Yun, Kyuho Kim, Donggyu Moon
Scientific Reports.2025;[Epub] CrossRef
Reduced risk of gastrointestinal bleeding associated with eupatilin in aspirin plus acid suppressant users: nationwide population-based study
Hyun Seok Lee, Ji Hyung Nam, Dong Jun Oh, Yeo Rae Moon, Yun Jeong Lim
The Korean Journal of Internal Medicine.2024; 39(2): 261. CrossRef
DA-9601 has protective effects comparable to those of proton pump inhibitor and rebamipide against nonsteroidal anti-inflammatory drugs-induced upper and lower gastrointestinal bleeding in patients with rheumatoid arthritis: A nationwide study using Korea
Min Wook So, Aran Kim, Seung-Geun Lee
Medicine.2024; 103(27): e38801. CrossRef